Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension

被引:1
|
作者
Zhang, Chang [1 ]
Tsang, Yuen [2 ]
He, Jinghua [3 ]
Panjabi, Sumeet [2 ]
机构
[1] Janssen Business Technol Commercial Data Sci, Titusville, NJ USA
[2] Janssen Sci Affairs LLC, Real World Value & Evidence, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA
[3] Janssen Sci Affairs LLC, Real World Res, Titusville, NJ USA
关键词
Hospitalization; Healthcare resource utilization; Predictive risk factors; Patient characteristics; Pulmonary arterial hypertension; SCORE CALCULATOR; SURVIVAL; REGISTRY; MANAGEMENT; OUTCOMES; COSTS;
D O I
10.1007/s12325-023-02501-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionUS claims-based analyses emphasize the substantial hospitalization burden of patients with pulmonary arterial hypertension (PAH) and the significant need for improved monitoring and more timely interventions. A claims-based predictive model may be useful to assist healthcare providers and payers in identifying patients with PAH at increased hospitalization risk. To address this aim, we constructed statistical models using baseline patient variables available in administrative healthcare claims to predict patients' risk for all-cause and PH-related hospitalization within 1 year of initiating >= 1 PAH indicated medication.MethodsAdult patients with PAH who newly initiated >= 1 PAH indicated medication were selected from the MarketScan Commercial and Medicare Supplemental databases (January 1, 2009-January 31, 2019). Cox regression models were built with a randomly selected training set and evaluated using a validation set of remaining patients. Predictive variables for the models were selected in three steps: clinical knowledge, univariate analysis, and backward stepwise selection.ResultsWithin 1 year of initiating >= 1 PAH indicated medication, 1502/3872 (38.8%) had an all-cause hospitalization and 950/3872 (24.5%) had a pulmonary hypertension (PH)-related hospitalization. Predictive risk factors for all-cause hospitalization were Quan-Charlson Comorbidity Index (CCI) score 2-3 [hazard ratio (HR) 1.229; P = 0.038] and >= 4 (HR 1.531; P < 0.001), claims-based frailty index (CFI) score > 1 (highest frailty level; HR 1.301; P = 0.018), hemoptysis (HR 1.254; P = 0.016), malaise/fatigue (HR 1.150; P = 0.037), history of PH-related hospitalization (HR 1.171; P = 0.011), non-PH-related ER visit (HR 1.713; P = 0.014), and higher non-PH-related outpatient visit cost (HR 1.069; P < 0.001). Predictive risk factors for PH-related hospitalization were female sex (HR 1.264; P = 0.004), Quan-CCI score >= 4 (HR 1.408; P = 0.008), portal hypertension (HR 1.565; P = 0.019), CFI score > 1 (HR 1.522; P = 0.002), dyspnea (HR 1.259; P = 0.023), and history of PH-related hospitalization (HR 1.273; P = 0.002).ConclusionsThe US claims-based predictive models showed acceptable performance to predict 1-year hospitalization among patients with PAH.
引用
收藏
页码:2481 / 2492
页数:12
相关论文
共 50 条
  • [41] Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
    Lewis, Robert A.
    Johns, Christopher S.
    Cogliano, Marcella
    Capener, David
    Tubman, Euan
    Elliot, Charlie A.
    Charalampopoulos, Athanasios
    Sabroe, Ian
    Thompson, A. A. Roger
    Billings, Catherine G.
    Hamilton, Neil
    Baster, Kathleen
    Laud, Peter J.
    Hickey, Peter M.
    Middleton, Jennifer
    Armstrong, Iain J.
    Hurdman, Judith A.
    Lawrie, Allan
    Rothman, Alexander M. K.
    Wild, Jim M.
    Condliffe, Robin
    Swift, Andrew J.
    Kiely, David G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (04) : 458 - 468
  • [42] Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis
    Liu, Yuqi
    Cheng, Zhen
    Zha, Bowen
    Chen, Xiaodong
    Gong, Zhiyu
    Ji, Lang
    Wei, Lingling
    LUPUS, 2023, 32 (11) : 1310 - 1319
  • [43] Exercise Hemodynamics in the Prognosis of Patients with Pulmonary Arterial Hypertension
    Faure, Morgane
    Valentin, Simon
    Zysman, Maeva
    Sitbon, Olivier
    Peretti, Laura
    Guillaumot, Anne
    Gomez, Emmanuel
    Huttin, Olivier
    Selton-Suty, Christine
    Chabot, Francois
    Chaouat, Ari
    RESPIRATION, 2020, 99 (08) : 678 - 685
  • [44] Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
    Hsu, Vivien M.
    Chung, Lorinda
    Hummers, Laura K.
    Shah, Ami
    Simms, Robert
    Bolster, Marcy
    Hant, Faye N.
    Silver, Richard M.
    Fischer, Aryeh
    Hinchcliff, Monique E.
    Varga, John
    Goldberg, Avram Z.
    Derk, Chris T.
    Schiopu, Elena
    Khanna, Dinesh
    Shapiro, Lee S.
    Domsic, Robyn T.
    Medsger, Thomas
    Mayes, Maureen D.
    Furst, Daniel
    Csuka, Mary Ellen
    Molitor, Jerry A.
    Saketkoo, Lesley Ann
    Salazar, Christian R.
    Steen, Virginia D.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (02) : 176 - 183
  • [45] Identifying consistent echocardiographic thresholds for risk stratification in pulmonary arterial hypertension
    Celestin, Bettia E.
    Bagherzadeh, Shadi P.
    Ichimura, Kenzo
    Santana, Everton J.
    Sanchez, Pablo Amador
    Tobore, Tobore
    Hemnes, Anna R.
    Noordegraaf, Anton Vonk
    Salerno, Michael
    Zamanian, Roham T.
    Sweatt, Andrew J.
    Haddad, Francois
    PULMONARY CIRCULATION, 2024, 14 (02)
  • [46] Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension
    Qaderi, Vazhma
    Weimann, Jessica
    Harbaum, Lars
    Schrage, Benedikt N.
    Knappe, Dorit
    Hennigs, Jan K.
    Sinning, Christoph
    Schnabel, Renate B.
    Blankenberg, Stefan
    Kirchhof, Paulus
    Klose, Hans
    Magnussen, Christina
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [47] Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids
    Bartolome, Sonja D.
    Sood, Namita
    Shah, Trushil G.
    Styrvoky, Kim
    Torres, Fernando
    Chin, Kelly M.
    CHEST, 2018, 154 (03) : 532 - 540
  • [48] Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort
    Huang, Wei
    FitzGerald, Gordon
    Goldberg, Robert J.
    Gore, Joel
    McManus, Richard H.
    Awad, Hamza
    Waring, Molly E.
    Allison, Jeroan
    Saczynski, Jane S.
    Kiefe, Catarina I.
    Fox, Keith A. A.
    Anderson, Frederick A.
    McManus, David D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (08) : 1105 - 1110
  • [49] Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension
    Stolfo, Davide
    Barbisan, Davide
    Ameri, Pietro
    Lombardi, Carlo Mario
    Monti, Simonetta
    Driussi, Mauro
    Zovatto, Isabella Carlotta
    Gentile, Piero
    Howard, Luke
    Toma, Matteo
    Pagnesi, Matteo
    Collini, Valentino
    Bauleo, Carolina
    Guglielmi, Giulia
    Adamo, Marianna
    D'Angelo, Luciana
    Nalli, Chiara
    Sciarrone, Paolo
    Moschella, Martina
    Zorzi, Barbara
    Vecchiato, Veronica
    Milani, Martina
    Di Poi, Emma
    Airo, Edoardo
    Metra, Marco
    Garascia, Andrea
    Sinagra, Gianfranco
    Lo Giudice, Francesco
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (08) : 1082 - 1092
  • [50] Derivation of a Risk Score (REVEAL- ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension
    El-Kersh, Karim
    Zhao, Carol
    Elliott, Gregory
    Farber, Harrison W.
    Gomberg-Maitland, Mardi
    Selej, Mona
    Garcia-Ferrer, Josephine
    Benza, Raymond
    CHEST, 2023, 163 (05) : 1232 - 1244